5 mg Serlopitant Tablets
MTI-107
Phase 3 small_molecule terminated
Quick answer
5 mg Serlopitant Tablets for Pruritus is a Phase 3 program (small_molecule) at VYNE Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- VYNE Therapeutics
- Indication
- Pruritus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated